PARADIGM BIO. ORDINARY (PAR) Short Interest

Name: PARADIGM BIO. ORDINARY (PAR) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

PARADIGM BIO. ORDINARY (ASX:PAR) had 0.01% of shares reported as short positions as of 4 June 2026, representing 48,151 shares. PARADIGM BIO. ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.01%
Reported positions: 48,151
Industry: Pharmaceuticals, Biotechnology & Life Sciences
As of: 4 June 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

PAR

Paradigm Biopharmaceuticals Limited..

Pharmaceuticals, Biotechnology & Life Sciences

Paradigm Biopharmaceuticals is a late-stage drug development company with the mission to develop and commercialise pentosan polysulfate sodium for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, ageing, dege

Shorted

short percentage0.01%

reported shorts48.2K

shares on issue525.457M